Oligomeric alpha-synuclein inhibits tubulin polymerization
- PMID: 17374364
- DOI: 10.1016/j.bbrc.2007.02.163
Oligomeric alpha-synuclein inhibits tubulin polymerization
Abstract
Earlier investigations have demonstrated that tubulin co-localizes with alpha-synuclein in Lewy bodies and influences the formation of alpha-synuclein aggregation. However, it is not clear whether aggregated alpha-synuclein has any effects on the function of tubulin, i.e. tubulin polymerization, a critical mechanism by which neurons maintain their morphology and execute functions. In this study, we evaluated the effects of aggregated alpha-synuclein on tubulin polymerization in dopaminergic neurons (MES cells), along with mitochondrial function, cell morphology, and viability. The results indicate that MES cells exposed to extracellular oligomeric alpha-synuclein exhibited decreased tubulin polymerization and mitochondrial function as well as morphological alternation long before cell death. Further investigation showed that internalization of oligomeric alpha-synuclein by neurons appeared to be critical in the process, although direct interaction between tubulin and intracellular oligomeric alpha-synuclein was not necessary. Finally, we demonstrated that neurotoxicity induced by oligomeric alpha-synuclein was largely prevented by overexpressing the neuroprotective protein, DJ-1.
Similar articles
-
Mechanisms of DJ-1 neuroprotection in a cellular model of Parkinson's disease.J Neurochem. 2008 Jun 1;105(6):2435-53. doi: 10.1111/j.1471-4159.2008.05333.x. J Neurochem. 2008. PMID: 18331584
-
Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.FASEB J. 2005 Apr;19(6):533-42. doi: 10.1096/fj.04-2751com. FASEB J. 2005. PMID: 15791003
-
The Parkinson's disease-associated DJ-1 protein is a transcriptional co-activator that protects against neuronal apoptosis.Hum Mol Genet. 2005 May 1;14(9):1231-41. doi: 10.1093/hmg/ddi134. Epub 2005 Mar 24. Hum Mol Genet. 2005. PMID: 15790595
-
[Parkinson's disease: what have we learned from the genes responsible for familial forms?].Med Sci (Paris). 2003 May;19(5):613-9. doi: 10.1051/medsci/2003195613. Med Sci (Paris). 2003. PMID: 12836396 Review. French.
-
[Advances in the genetic studies in Parkinson's disease].Neurol Neurochir Pol. 2004 Mar-Apr;38(2):127-36. Neurol Neurochir Pol. 2004. PMID: 15307606 Review. Polish.
Cited by
-
Microtubule depolymerization potentiates alpha-synuclein oligomerization.Front Aging Neurosci. 2010 Jan 4;1:5. doi: 10.3389/neuro.24.005.2009. eCollection 2010. Front Aging Neurosci. 2010. PMID: 20552056 Free PMC article.
-
Dysfunctional energy and future perspective of low dose H2O2 as protective agent in neurodegenerative disease.Heliyon. 2023 Jul 16;9(7):e18123. doi: 10.1016/j.heliyon.2023.e18123. eCollection 2023 Jul. Heliyon. 2023. PMID: 37519743 Free PMC article. Review.
-
Implications of peptide assemblies in amyloid diseases.Chem Soc Rev. 2017 Oct 30;46(21):6492-6531. doi: 10.1039/c7cs00372b. Chem Soc Rev. 2017. PMID: 28702523 Free PMC article. Review.
-
Alpha-synuclein oligomers: a new hope.Acta Neuropathol. 2017 Dec;134(6):819-838. doi: 10.1007/s00401-017-1755-1. Epub 2017 Aug 12. Acta Neuropathol. 2017. PMID: 28803412 Free PMC article. Review.
-
Oleuropein derivatives from olive fruit extracts reduce α-synuclein fibrillation and oligomer toxicity.J Biol Chem. 2019 Mar 15;294(11):4215-4232. doi: 10.1074/jbc.RA118.005723. Epub 2019 Jan 17. J Biol Chem. 2019. PMID: 30655291 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous